TYK2 inhibition: changing the treatment landscape for psoriasis?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TYK2 inhibition: changing the treatment landscape for psoriasis?

Published:2021-11-23 Issue: Volume: Page:1-3
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Abduelmula Abrahim¹,Gooderham Melinda J.²³⁴^ORCID

Affiliation:

1. Faculty of Medicine, University of Western Ontario, London, Ontario, Canada

2. Department of Medicine, Queen’s University, Kingston, Ontario, Canada

3. Department of Medicine SKiN Centre for Dermatology, Peterborough, Ontario, Canada

4. Department of Medicine Probity Medical Research, Peterborough, Ontario, Canada

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2022.2008240

Reference10 articles.

2. Psoriasis pathogenesis and the development of novel targeted immune therapies

3. Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Study of Humoral Immune Response to Inactivated COVID-19 Vaccine in Patients with Psoriasis Receiving Biologics and Small Molecules;Clinical, Cosmetic and Investigational Dermatology;2024-07

2. A guide to prescribing systemic treatments for psoriasis during pregnancy, breastfeeding and in those trying to conceive: what does the current evidence suggest?;Clinical and Experimental Dermatology;2024-05-21

3. Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation;Expert Opinion on Drug Safety;2024-05-06

4. Progress on the Pharmacological Targeting of Janus Pseudokinases;Journal of Medicinal Chemistry;2023-08-14

5. Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis;Therapeutics and Clinical Risk Management;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3